In preclinical models, numerous studies have demonstrated that increased tumor growth and tumor immune evasion are associated with the expression and activity of the CD73/adenosine system in the tumor microenvironment (Table 1) [69,70]. The gene discussed is NT5E; the disease is neoplasm.